# FDA 483 - GlaxoSmithKline Biologicals - March 12, 2024

Source: https://www.globalkeysolutions.net/records/483/glaxosmithkline-biologicals/9e7e7917-0ccb-407d-a24c-5f2e85efb021

> FDA 483 for GlaxoSmithKline Biologicals on March 12, 2024. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: GlaxoSmithKline Biologicals
- Inspection Date: 2024-03-12
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Officers

- [Consumer Safety Officer at Commissioned Corps of the U.S. Public Health Service](https://www.globalkeysolutions.net/people/latorie-s-jones/086d0897-7d63-4fa8-bdce-f1d17885abd7)
- [Gregory S. Stone](https://www.globalkeysolutions.net/people/gregory-s-stone/6fc15653-2d1b-46d6-89dd-655a40ea72de)
- [Consumer Safety Officer](https://www.globalkeysolutions.net/people/mark-w-jackson/d4c56fee-b58d-4f39-aa7a-996f86282cc3)

Company: https://www.globalkeysolutions.net/companies/glaxosmithkline-biologicals/98ade6fb-8ae1-48af-a7cf-71b26cd2e808

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d